Viva Flashcards

1
Q

Why have you stated that depressed skull fractures, craniotomy, IVH and neurosurgical intervention are risk factors and not analysed them later?

A

Because these factors were not well represented in the data and are well established already

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the pfausler cell index?

Why did you not use it?

A

Pfausler et al. 2004 devised a measure to aid in csf-infection diagnosis. It is ratio of leukocytes:erythrocytes in csf divided by same measure in peripheral blood. Rise in this is characteristic of infection.

It is not used because calculating the cell index requires routine sampling and this is not advocated in the QMC as it is a risk factor.

Beer and lackner both utilised this though

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What do Mayhall et al., Holloway et al. And Lo et al. 07 all say about elective revision?

A

Mayhall et al. After 5 days review as inf rate soars
Holloway et al. Rises up to ten days but then drops off
Lo et al. Argued against elective revision saying infection risk increases with each new EVD, retrograde col

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the issue with antibiotic prophylaxis?

A

Resistant pathogens.
Poon et al. 1998 compared one course peri vs high dose dual therapy prophylaxis and in spite of lower inf rates selection for mrsa and candida spp. Occurred

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What did Wyler and Kelly find?

Limitations?

A

If EVD was to be in situ longer than 3 days then prophylactic abx should be used.

Limited study though, only 11 infections and average duration of EVD in situ was very short (2.5 and 5 days)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What was the issue with studies by rebuck et al. And alleyne et al. (2000)?

A

Antibiotic prophylaxis,
Rebuck- no significant effect of prophylaxis on rate
Alleyne - no sig effect
Both weak because of poor sample size.
Rebuck et al. Chose narrow spec cephalosporins as management and this negatively impacted result.
Poon et al chose broad spec

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Why is inadequate antibiotic use a problem?

A

Can result in resistant/ different microbiological profiles. Ibrahim et al. Bloodstream infections 2000 - translates to csf infections, adequate and early abx is important to prevent neurological impairment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the view on systemic infection as a risk factor for csf infection?

A

Kim et al. 2012 no sig result
Clark et al. 1989 found relationship so did Holloway et al. 1996
Schultz et al found no relationship

Kim et al. Found similarities in organism between systemic and EVD culture isolates. This conflicts Clark et al. Where they stated it is different. Requires further research as it may be important in terms of managing it

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Why would flushing a catheter be a risk factor? Any evidence?

A

Breaching a closed system and providing potential site of entry for pathogens.
Aucoin et al. 1986 flushed EVDs with antibiotic solution but actually found 6% increase of rr ventriculitis in those that received the flush

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Which papers commented on leaks as a risk factor?

A

Mayhall et all. 1984 and Schultz et al. 1993 found no link between leaks and EVD-infection.

Lyke et al. Found that leaks were a risk factor and irrigation was not! However small sample size of flushed patients is reason and they think leaks provide longer opportunity for pathogens

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the bactiseal EVD made of?

A

Silicone matrix flexible catheter, imoregnated with 0.15% clindamycin and 0.054% rifampicin.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How do you know Bactiseal EVD works?

A

In vitro studies by prof Bayston have shown protection against bacterial colonisation from staphylococci.
In vivo studies by zabramski 03 lackner 08 and Harrop 10 show efficacy of AICs fighting infection

Pople et al. 2012 dismissed because of poor recruitment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Why is the Wong 2010 study important if it shows no benefit from using an AIC compared to prophylaxis?

A

It shows non-inferiority.
3 x cases of C.Diff colitis in prophylaxis group shows that the risk of resistant pathogens is not evident in AICs as it is with systemic long term prophylaxis.

Also investigated if impregnation made the catheter stiffer which it did not, which did happen in catheter mentioned by Stevens et al. 09

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the problem with the study by Gutierrez-Gonzalez et al. 2010?

A

Assessed shunts and EVDs together in order to adjust for low numbers of EVD infections. In terms of EVDs infection rates were very high in both control and bactiseal. Bactiseal EVDs showed a trend towards lower inf rates

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What were the outcomes from an in vitro analysis of the minocycline and rifampin AIC?

A

Stevens et al. 2009, showed antibiotic effects on colonisation as expected but unexpectedly AICs were more likely to give false negatives.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Stevens et al. 2009s findings were overturned in 2015, why?

A

Bayston 2015 evaluated effect of AICs in bacterial viability in vitro. Ran study over a period of 21 days as opposed to just one day like in Stevens. Evaluated 3 AICs, and showed that after day 1 bacterial viability was no longer an issue and argued that samples are not taken in the first day post insertion anyway

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Tell me about the findings of Thomas et al. 2012

A

Meta-analysis to review antibiotic impregnated csf devices. Found significant results in favour of AICs but concluded that this is largely on basis of observational studies and RCTs are needed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Some of these papers you have quoted on silver catheters say they are significant in reducing infection, is that so?

A

Lackner et al. 2008 pilot study - Didn’t have one single infection in the silver arm of study - selection bias and small sample size.

Lacjak et al. 2013 only obtained significant result when data were manipulated - added different brand plain catheter with much higher infection rate in order to make silver one significantly better.

Keong et al. Double blind prospective RCT recorded a very high infection rate 21.4% and plain and silver only became significantly different after 10 days in situ.

All of these have doubts in integrity and accuracy

19
Q

What did Hagel et al. 2014 find?

A

Trend towards silver catheters increasing infection rates. However v small number of infections in both groups

20
Q

What studies compared the efficacy of silver and AICs?

A

Winkler et al. 2013 RCT found no sig difference but had a small sample size and unfamiliar diagnostic criteria

Wang et al 2013 meta analysis found no stat sig difference between silver and plain but did between AIC and plain.

Wang et al. Is a good study of high importance.

21
Q

What is the basics trial?

A

British antibiotic and silver impregnated catheters for ventriculoperitoneal shunts.
Multi-centre RCT
Ongoing trial recruits from QMC and others across the country. Will hopefully provide solid evidence to support reduced infection rates in both cases and also inspire a similar trial in EVDs as is needed.

22
Q

Why was your sample chosen and not done at random?

A

Of 874 EVDs placed only 111 from 59 pts were included. They were chosen because they were previously identified as having suspected EVD-infections but there were doubts on the legitimacy of this. All patients not selected were definitely not EVD-infections and hence the rate could still be calculated.

23
Q

Why was your criteria used?

A

It was in accordance with the literature and professional opinion (supervisor).

24
Q

Why were the recognised pathogens chosen?

A

S aureus E. coli klebsiella enterococcus pseudomonas and candida are common csf pathogens

25
Q

Why did you use the overall rate and not the definite one?

A

It is unclear as to whether or not a definite rate was calculated in the previous audit. Therefore using the overall is more appropriate.

26
Q

What does the breakdown of organisms mean?

A

In accordance with microbiological profiles of other studies CONS and gram negative bacilli are predominant. No evident selection is apparent which means no selective pressure is exerted by the AIC however a breakdown from the previous internal audit would be more useful.

27
Q

What are the tests used for goodness of fit?

A

Hosted-lemeshow test and omnibus tests of model coefficients also gave chi square value

28
Q

Why is the probable criterion so complex?

A

Clinical signs added as these are used in other studies (smith and Alksne, Clark et al and sundbarg et al) as well as csf pleocytosis/ glucose along with cultures from tips, one culture only and a gram stain result. 2 of the 3 categories eliminates possibility of contaminants (reduced false positive). Note clinical signs should not be depended upon when population is mostly unconscious

29
Q

You’ve used EVD tip cultures but said they’re not useful?

A

Wong et al. 2010 stated that 7 EVD tips gave positive results without evidence of ventriculitis. Hence tip results may produce false positives but combining with other elements should help prevent this

30
Q

What vital pieces of info are you missing from the previous internal audit?

A

Breakdown of organisms
Criteria used
Proportion definite
Antibiotic protocols

31
Q

Wang et al. 2013 produced what result that adds substance to mine?

A

Systematic review on AICs that yielded a 3.6% infection rate (close to 3.09%). Suggests they are effective

32
Q

What trend was seen with each new catheter per patient?

A

Protection against infection. Contrary to other studies (Lo et al 07 and Clark et al 89) infection gets less likely - does bactiseal have a protective effect? Larger sample sizes of patients with several EVDs required to test this. Only 12 of 59 patients analysed had 3+ EVDs.

33
Q

Which study does Wong et al 2002 directly contradict?

A

Mayhall et al 84 as it says there is no benefit to predetermined exchange after 5 days post insertion when compared with clinical presentation demanding it

34
Q

Why are peaks of infection seen so early in studies?

Why is our study so much later?

A

Most studies have short duration EVDs approx 5 or 6 days. (They aren’t like urinary catheters). E.g aucoin Mayhall and Clark

This lack of sample size could explain peaks at these times. A large sample of long duration EVDs (our average duration was 14.2 days) could explain the later peak in incidence as well as the protective effect of the bactiseal carheter.

35
Q

Why are so many of the patients on abx and what does this mean?

A

Due to nature of the population, 58 of 111 were receiving abx at insertion and 75 of 111 experienced a concomitant infection. A random sample would not have experienced this. Could contribute to low rate of infection recorded

36
Q

How did the irrigation and sampling protocols affect the results?

A

Flushes as a last resort only. Nearly 75% of EVDs not flushed. Wider sample required to assess this as a risk factor but could contribute to low rate

Sampling when suspicion of infection only. Hoefnagel et al 08 linked samples and breaches to EVD-infection. Lots of samples were often taken to check if infection had cleared in a new EVD negatively impacting analysis

These two risk factors should be analysed in a randomised sample but they both may contribute to low rate.

37
Q

What did Lyke et al. 2001 find?

A

9 of 11 infections were g neg bacilli they attributed this to use of broad spectrum gram pos prophylaxis for every single patient. This is problematic as gram neg infections are harder to treat and are associated with high rates of mortality and morbidity.

38
Q

Why is a rise in gram positive infections observed?

A

Data is warped by just one or 2 cases. Monthly reputation may be required. Perhaps promotes rise of resistant skin flora.

39
Q

How do you know bactiseal doesn’t promote resistance?

A

Gram negatives are still in minority, organisms are concordat with normal skin flora and literature and there is no obvious selection for organisms. Also the drugs are released at non toxic concentrations very slowly - not in mutant selection window

40
Q

Is the Bactiseal EVD effective against all organisms?

A

No it is proven to be effective against staphylococci. Wang et al. 2013 showed a non sig trend do wards decreasing infection rates regarding gram negative bacilli but this requires further research

41
Q

What are the strengths and weaknesses of the study?

A

Strengths: same researcher, use of predetermined trusted criteria, similarities with wang et al. 2013.

Weaknesses: retrospective, selection bias, mismatch of info with previous internal audit

42
Q

Why is this study incomplete?

A

Missing data and sample means risk factor analysis is incomplete. It also requires multi centre randomised controlled trials like the BASICS trial

43
Q

Why is the range of infection rates so wide?

A

0-22% Lozier et al. 2002

Varies depending on the patient population, antibiotic protocols and criteria for defining infection